These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23395085)

  • 1. Persistence of anti-human leukocyte antibodies in congenital heart disease late after surgery using allografts and whole blood.
    O'Connor MJ; Lind C; Tang X; Gossett J; Weber J; Monos D; Shaddy RE
    J Heart Lung Transplant; 2013 Apr; 32(4):390-7. PubMed ID: 23395085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panel-reactive antibodies late after allograft implantation in children.
    Hooper DK; Hawkins JA; Fuller TC; Profaizer T; Shaddy RE
    Ann Thorac Surg; 2005 Feb; 79(2):641-4; discussion 645. PubMed ID: 15680851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts.
    Hawkins JA; Hillman ND; Lambert LM; Jones J; Di Russo GB; Profaizer T; Fuller TC; Minich LL; Williams RV; Shaddy RE
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):247-52; discussion 252-3. PubMed ID: 12878962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome.
    Di Filippo S; Girnita A; Webber SA; Tsao S; Boyle GJ; Miller SA; Gandhi SK; Zeevi A
    Hum Immunol; 2005 May; 66(5):513-8. PubMed ID: 15935888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients.
    Hawkins JA; Breinholt JP; Lambert LM; Fuller TC; Profaizer T; McGough EC; Shaddy RE
    J Thorac Cardiovasc Surg; 2000 Feb; 119(2):324-30. PubMed ID: 10649208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation.
    Meyer SR; Campbell PM; Rutledge JM; Halpin AM; Hawkins LE; Lakey JR; Rebeyka IM; Ross DB
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):554-60. PubMed ID: 15784350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen-year single-center experience with the Norwood operation for complex lesions with single-ventricle physiology compared with hypoplastic left heart syndrome.
    Hansen JH; Petko C; Bauer G; Voges I; Kramer HH; Scheewe J
    J Thorac Cardiovasc Surg; 2012 Jul; 144(1):166-72. PubMed ID: 22244563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaraldehyde treatment of allograft tissue decreases allosensitization after the Norwood procedure.
    Laing BJ; Ross DB; Meyer SR; Campbell P; Halpin AM; West LJ; Rebeyka IM
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1402-8. PubMed ID: 20236668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oversizing cardiac allografts on survival in pediatric patients with congenital heart disease.
    Razzouk AJ; Johnston JK; Larsen RL; Chinnock RE; Fitts JA; Bailey LL
    J Heart Lung Transplant; 2005 Feb; 24(2):195-9. PubMed ID: 15701437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
    Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
    J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification, identification, and relevance of anti-human leukocyte antigen antibodies formed in association with the berlin heart ventricular assist device in children.
    O'Connor MJ; Harville TO; Rhodes-Clark B; Pye SE; Knecht KR; Imamura M; Frazier EA; Morrow WR
    Transplantation; 2013 Jun; 95(12):1542-7. PubMed ID: 23778570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts.
    Kneib C; von Glehn CQ; Costa FD; Costa MT; Susin MF
    Tissue Antigens; 2012 Aug; 80(2):165-74. PubMed ID: 22631597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children.
    Stastny P; Lavingia B; Fixler DE; Yancy CW; Ring WS
    Transplantation; 2007 Sep; 84(6):738-45. PubMed ID: 17893607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of prophylactic intravenous immunoglobulin to prevent sensitization to cryopreserved allograft tissue used in congenital cardiac surgery.
    Meyer SR; Ross DB; Forbes K; Hawkins LE; Halpin AM; Nahirniak SN; Rutledge JM; Rebeyka IM; Campbell PM
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1517-23. PubMed ID: 17532950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of anti-human leukocyte antigen, anti-major histocompatibility complex class 1 chain-related antigen a, and anti-glutathione transferase-T1 antibodies on the long-term survival of renal allograft.
    Akgul SU; Oğuz FS; Çalışkan Y; Kekik C; Çağatay P; Türkmen A; Nane I; Aydın F; Temurhan S
    Transplant Proc; 2013 Apr; 45(3):890-4. PubMed ID: 23622580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.